Why adjuvant trastuzumab led to better outcomes in women with high-risk HER-2-positive breast cancer


Altundag K., Baptista M. Z.

BREAST JOURNAL, cilt.12, ss.497-498, 2006 (SCI İndekslerine Giren Dergi) identifier identifier identifier